ArticleJBMR plus2024

Targeting the osteoclastogenic cytokine IL-9 as a novel immunotherapeutic strategy in mitigating inflammatory bone loss in post-menopausal osteoporosis.

Leena Sapra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.